Annual Meeting of the American College of Cardiology March 11-14, 2006, Atlanta: Atheroma Reversal, Statins for Acute Coronary Syndromes, Targeting Dual Antiplatelet Therapy, Clopidogrel and Drug Elut

Annual Meeting of the American College of Cardiology March 11-14, 2006, Atlanta: Atheroma Reversal, Statins for Acute Coronary Syndromes, Targeting Dual Antiplatelet Therapy, Clopidogrel and Drug Eluting Stents, Catheter Ablation for Atrial FibrillationJames Tcheng, Duke University, Durham, NCREFERENCE: American College of Cardiology Annual Scientific Session March 11-14, 2006, AtlantaThe 2006 meeting of the ACC in Atlanta heard fromSteven Nissenof the Cleveland Clinic, Ohio how atheroma was observed to significantly regress among patients treated with a statin in the ASTEROID study, and fromAnthony Bavry– also of the Clinic – on how early aggressive use of statins helped patients with acute coronary syndromes. Peter Goodwin discussed these findings withJames Tchengwho also talks about the CHARISMA trial of dual anti-platelet therapy reported to the ACC by the Cleveland Clinic’sDeepak Bhatt, the BASKET study of late stent thrombosis in drug eluting stents presented in Atlanta byMatthias Pfistererfrom the University of Basel, and results ofCarlo Papponefrom San Raffaele University, Milan, on radio frequency ablation for paroxysmal atrial fibrillation.
Related Episodes

Remove Thrombus Before Primary Angioplasty!
Felix Zijlstra Felix Zijlstra, University Medical Center Groningen, The Netherlands Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits,

Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results
Philip Barter Gordon Tomaselli REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida N Engl J Med 2007;357 PHILIP BA

